The Cost Trend Drivers Behind GLP-1 Medications

The Cost Trend Drivers Behind GLP-1 Medications

GLP-1 medications have recently risen to the top of healthcare trends. In turn, they have become one of the fastest-growing drivers of pharmacy spend for health plans.

Originally developed to treat type 2 diabetes, GLP-1s are now increasingly prescribed for weight management and obesity-related conditions. As demand outside of their original use grows, employers must learn to balance access to innovative therapies with long-term financial sustainability.

Understanding the factors driving GLP-1 costs upward is essential to proactively managing pharmacy spend and protecting your health plan.

How GLP-1s are causing rising pharmacy costs

Rapid increase in utilization

One of the largest reasons behind GLP-1-driven pharmacy costs is simple: more people are using them than ever before.

As awareness of these medications’ weight-loss outcomes have increased, demand has expanded beyond the traditional use for diabetes management. For self-funded plans, even a modest increase in utilization can significantly impact pharmacy spend.

High cost per member

GLP-1 medications are expensive, often costing employers and members hundreds of dollars (or more) per month per prescription.

Unlike short-term therapies, GLP-1s are commonly used as ongoing, maintenance medications. This creates a compounding financial impact in which higher monthly spend over a longer period of time results in long-term financial risk.

Expanded clinical uses

GLP-1s continue to receive expanded approvals and broader clinical use cases beyond their original use for diabetes treatment. As these medications become associated with weight management, cardiovascular risk reduction, and metabolic health improvement, more members may qualify for coverage under existing plan structures.

While these developments can improve health outcomes, they also increase financial pressure on employers without clear utilization management strategies.

The challenge for self-funded employers

For many employers, GLP-1s present a difficult balancing act. 

On one hand, these medications can improve health outcomes and reduce long-term chronic disease risk. They also support member satisfaction and engagement with the health plan.

On the other hand, unmanaged utilization can increase pharmacy costs and threaten plan sustainability.

For employers on a traditional PBM plan, GLP-1 utilization can become one of the largest threats to their plan’s sustainability. With limited visibility and a lack of transparent data, traditional PBM contracts often force employers to react to rising costs after their spend has already escalated.

A proactive approach to managing GLP-1 spend

Controlling costs of GLP-1s and other expensive specialty medications does not mean eliminating access for your members. Instead, it means adopting a health plan strategy that includes:

• Clinical review and utilization management: Ensures GLP-1 therapies are prescribed appropriately and aligned with evidence-based care guidelines.

• Transparent oversight: Provides employers with visibility into utilization, pricing, and long-term trend impact.

• Personal importation: Gives access to GLP-1s at significantly lower costs.

• Integrated data and reporting: Uses pharmacy and medical claims data together to identify trends early.

VeracityRx is OneVeracity’s solution for integrated pharmacy management. Rather than operating like a traditional PBM, VeracityRx empowers employers to take a holistic approach and manage cost, access, and member support simultaneously.

The Bottom Line

GLP-1 medications are reshaping the pharmacy landscape. While these therapies offer meaningful benefits, they also are a growing source of financial pressure for self-funded employers.

By taking a proactive, integrated approach to manage pharmacy spend, employers can protect their health plan’s sustainability without compromising on member care or pharmaceutical offerings. VeracityRx helps employers navigate rising pharmacy costs by addressing the root causes of increasing cost, not just the symptoms. Our integrated solutions are designed to reduce financial risk while supporting better member outcomes.

Learn more about VeracityRx’s integrated pharmacy solutions that value transparency, reduce financial risk, and prioritize member support.

‍